Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
American Journal of Cancer Research|July 19, 2016
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?Muneyuki Masuda, Takahiro Wakasaki, Satoshi Toh
Auris, Nasus, Larynx|July 14, 2015
Combined transcervical and orbitozygomatic approach for the removal of a nasopharyngeal adenocarcinomaMuneyuki Masuda, Junichi Fukushima, Akiko Fujimura, et al.
Biomedicine Hub|January 29, 2020
Transmanubrial Approach for Removing a Head and Neck Tumor Located at the Upper Lateral MediastinumMuneyuki Masuda, Fumihide Rikimaru, Satoshi Toh, et al.
Nihon Jibiinkoka Gakkai Kaiho|August 9, 2014
[A case of squamous cell carcinoma of the hard palate in a patient with basal cell nevus syndrome]Mioko Matsuo, Fumihide Rikimaru, Yuichiro Higaki, et al.
Nihon Jibiinkoka Gakkai Kaiho|September 5, 2015
[Spindle Cell Carcinoma of the Head and Neck: A Report of 6 Cases]Mioko Matsuo, Fumihide Rikimaru, Yuichiro Higaki, et al.
International Journal of Surgery Case Reports|February 2, 2016
A case of hypopharyngeal cancer with stenosis, perforation, and pyogenic spondylitis development after chemoradiotherapyMioko Matsuo, Fumihide Rikimaru, Yuichiro Higaki, et al.
Journal of Oncology|January 29, 2011
Chemoprevention of Head and Neck Cancer by Green Tea Extract: EGCG-The Role of EGFR Signaling and "Lipid Raft"Muneyuki Masuda, Takahiro Wakasaki, Satoshi Toh, et al.
Molecular Nutrition & Food Research|May 4, 2011
Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinasesMasahito Shimizu, Seiji Adachi, Muneyuki Masuda, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 10, 2004
Cyclin D1 expression does not effect cell proliferation in adenoid cystic carcinoma of the salivary glandRyuji Yasumatsu, Yuichiro Kuratomi, Torahiko Nakashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cellsMuneyuki Masuda, Masumi Suzui, Jin T E Lim, et al.
Pageof 10